Recombinant Carboxypeptidase B Market Report – Research, Industry Analysis Reports and Market Demands

Global Recombinant Carboxypeptidase B Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Carboxypeptidase B Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 ＞90%
- 1.3.3 ＞95%
- 1.3.4 Others
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Carboxypeptidase B Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Functional Studies
- 1.4.3 SDS-PAGE
- 1.4.4 HPLC
- 1.4.5 Others
1.5 Global Recombinant Carboxypeptidase B Market Size & Forecast
- 1.5.1 Global Recombinant Carboxypeptidase B Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Recombinant Carboxypeptidase B Sales Quantity (2021-2032)
- 1.5.3 Global Recombinant Carboxypeptidase B Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Recombinant Carboxypeptidase B by Manufacturer

3.1 Global Recombinant Carboxypeptidase B Sales Quantity by Manufacturer (2021-2026)
3.2 Global Recombinant Carboxypeptidase B Revenue by Manufacturer (2021-2026)
3.3 Global Recombinant Carboxypeptidase B Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Recombinant Carboxypeptidase B by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Recombinant Carboxypeptidase B Manufacturer Market Share in 2025
- 3.4.3 Top 6 Recombinant Carboxypeptidase B Manufacturer Market Share in 2025
3.5 Recombinant Carboxypeptidase B Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Carboxypeptidase B Market: Region Footprint
- 3.5.2 Recombinant Carboxypeptidase B Market: Company Product Type Footprint
- 3.5.3 Recombinant Carboxypeptidase B Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Recombinant Carboxypeptidase B Market Size by Region
- 4.1.1 Global Recombinant Carboxypeptidase B Sales Quantity by Region (2021-2032)
- 4.1.2 Global Recombinant Carboxypeptidase B Consumption Value by Region (2021-2032)
- 4.1.3 Global Recombinant Carboxypeptidase B Average Price by Region (2021-2032)
4.2 North America Recombinant Carboxypeptidase B Consumption Value (2021-2032)
4.3 Europe Recombinant Carboxypeptidase B Consumption Value (2021-2032)
4.4 Asia-Pacific Recombinant Carboxypeptidase B Consumption Value (2021-2032)
4.5 South America Recombinant Carboxypeptidase B Consumption Value (2021-2032)
4.6 Middle East & Africa Recombinant Carboxypeptidase B Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
5.2 Global Recombinant Carboxypeptidase B Consumption Value by Type (2021-2032)
5.3 Global Recombinant Carboxypeptidase B Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
6.2 Global Recombinant Carboxypeptidase B Consumption Value by Application (2021-2032)
6.3 Global Recombinant Carboxypeptidase B Average Price by Application (2021-2032)

7 North America

7.1 North America Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
7.2 North America Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
7.3 North America Recombinant Carboxypeptidase B Market Size by Country
- 7.3.1 North America Recombinant Carboxypeptidase B Sales Quantity by Country (2021-2032)
- 7.3.2 North America Recombinant Carboxypeptidase B Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
8.2 Europe Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
8.3 Europe Recombinant Carboxypeptidase B Market Size by Country
- 8.3.1 Europe Recombinant Carboxypeptidase B Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Recombinant Carboxypeptidase B Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Recombinant Carboxypeptidase B Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Recombinant Carboxypeptidase B Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
10.2 South America Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
10.3 South America Recombinant Carboxypeptidase B Market Size by Country
- 10.3.1 South America Recombinant Carboxypeptidase B Sales Quantity by Country (2021-2032)
- 10.3.2 South America Recombinant Carboxypeptidase B Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Recombinant Carboxypeptidase B Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Recombinant Carboxypeptidase B Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Recombinant Carboxypeptidase B Market Drivers
12.2 Recombinant Carboxypeptidase B Market Restraints
12.3 Recombinant Carboxypeptidase B Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Recombinant Carboxypeptidase B and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Carboxypeptidase B
13.3 Recombinant Carboxypeptidase B Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Recombinant Carboxypeptidase B Typical Distributors
14.3 Recombinant Carboxypeptidase B Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Recombinant Carboxypeptidase B market size was valued at US$ 575 million in 2025 and is forecast to a readjusted size of US$ 1057 million by 2032 with a CAGR of 9.2% during review period.
Recombinant carboxypeptidase B is an enzyme obtained through genetic engineering technology. The gene of recombinant carboxypeptidase B usually comes from organisms in nature, such as Escherichia coli or Pichia pastoris. Through cloning, expression and purification, the recombinant carboxypeptidase B is separated and purified from recombinant Pichia pastoris or Escherichia coli, and then freeze-dried to obtain the lyophilized powder of recombinant carboxypeptidase B.
Recombinant carboxypeptidase B belongs to the metallocarboxypeptidase family, and each molecule contains one Zn atom. It has the ability to specifically hydrolyze the amino end of the C-terminal basic amino acids of proteins (such as lysine, arginine, and histidine). This characteristic makes it have a wide range of application potential in protein sequence analysis, modification, and peptide synthesis.
The activity of recombinant CPB is inhibited by typical metal chelators such as EDTA, and Cu²⁺ and Hg²⁺.
Metal ions such as Zn²⁺ and Mn²⁺ can increase the enzyme activity to varying degrees. The optimal pH of CPB is 8.0. Acidic or alkaline conditions will cause a decrease in activity. When the pH is close to 5.0, the activity is close to zero, and when the pH>12.0, the activity is completely lost. Within a certain temperature range (<60°C), the activity of CPB increases with increasing temperature.
With the continuous development and optimization of genetic engineering technology, the production efficiency and purity of recombinant carboxypeptidase B have been significantly improved, reducing production costs and enhancing market competitiveness. The introduction of new technologies, such as enzyme engineering and fermentation engineering, has further promoted the innovation of the production process of recombinant carboxypeptidase B and improved the yield and quality.
Recombinant carboxypeptidase B has a wide range of applications in biomedicine, scientific research, industrial production and other fields. With the continuous development of these fields, the demand for recombinant carboxypeptidase B is also growing continuously. Especially in the field of biomedicine, recombinant carboxypeptidase B plays an important role in the production of biological drugs such as insulin and antibodies. With the continuous expansion of the biological drug market, its demand will also increase further.
The government's support policies and capital investment in the biopharmaceutical industry have provided strong support for the research and development and production of recombinant carboxypeptidase B. The increase in research and development investment by scientific research institutions and enterprises has promoted the continuous innovation and upgrading of recombinant carboxypeptidase B related technologies.
With the aging of the global population and the improvement of health awareness, the demand for biopharmaceutical products continues to increase, driving the growth of the recombinant carboxypeptidase B market. In addition, the application of recombinant carboxypeptidase B in industrial fields such as food and cosmetics has gradually expanded, further promoting the expansion of the market.
This report is a detailed and comprehensive analysis for global Recombinant Carboxypeptidase B market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Carboxypeptidase B market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Recombinant Carboxypeptidase B market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Recombinant Carboxypeptidase B market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Recombinant Carboxypeptidase B market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Carboxypeptidase B
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Carboxypeptidase B market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, PeproTech, Prospec Bio, BPS Bioscience, Shanghai Yaxin Biotechnology Co., Ltd., R&D Systems, RayBiotech, Abcam, Advent Bio, Innovative Researc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Carboxypeptidase B market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
＞90%
＞95%
Others
Market segment by Application
Functional Studies
SDS-PAGE
HPLC
Others
Major players covered
Roche
PeproTech
Prospec Bio
BPS Bioscience
Shanghai Yaxin Biotechnology Co., Ltd.
R&D Systems
RayBiotech
Abcam
Advent Bio
Innovative Researc
enQuire BioReagents
Lonza Bioscience
Boster Bio
ProSci
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Carboxypeptidase B product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Carboxypeptidase B, with price, sales quantity, revenue, and global market share of Recombinant Carboxypeptidase B from 2021 to 2026.
Chapter 3, the Recombinant Carboxypeptidase B competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Carboxypeptidase B breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Carboxypeptidase B market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Carboxypeptidase B.
Chapter 14 and 15, to describe Recombinant Carboxypeptidase B sales channel, distributors, customers, research findings and conclusion.

Buy now